News for ProPhase Labs, Inc. (PRPH)

Release Date: March 31, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ProPhase Labs I

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NPRPH.OQ - Prophase Labs IncQ4 2024 Prophase Labs Inc Earnings CallMar 31, 2025 / 03:00PM GMT =

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Conference Call March 31, 2025 11:00 AM ETCompany ParticipantsNoella Alexander-Young - Virtual Event...

The following slide deck was published by ProPhase Labs, Inc.

ProPhase Labs reports FY GAAP EPS of -$2.61 with an 80.6% net revenue decrease to $6.8M.

ProPhase Labs (PRPH) set to report FY earnings on March 31. Consensus EPS: -$0.24 (+75.5% Y/Y), Revenue: $13.02M (-71.2% Y/Y).

GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( PRPH) (”œProPhase” or the ”œCompany”), a next-generation biotech, genomics, an

ProPhase Labs (PRPH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

**media[549726]**

Company Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Inv

ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures

GARDEN CITY, NY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( PRPH) (”œProPhase” or the ”œCompany”), a next-generation biotech, genomics, and

ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles

**media[521478]**

ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline

The Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( PRPH) (”œPro

Capital Raise: Executed to support aggressive launch of DNA Complete and DNA Expand, and to address cash flow imbalance due to delayed customer payments.Expens

Nov 13, 2024 / 04:00PM GMTNoella Alexander Young - Renmark Financial communications - virtual event moderator Hello and good morning, everyone. Welcome to today

Noella Alexander-Young: Hello, and good morning, everyone. Welcome to today's presentation. My name is Noella Alexander-Young, the virtual event moderator here at Redmark Financial Communications.